Cargando…
Cardiovascular events and mortality in chronic kidney disease in primary care patients with previous type 2 diabetes and/or hypertension. A population-based epidemiological study (KIDNEES)
BACKGROUND: Chronic Kidney Disease (CKD), Type 2 Diabetes (T2D) and Hypertension (HTN) are frequently associated with adverse outcomes. We aimed to estimate the impact of a prior diagnosis of T2D and/or HTN on clinical characteristics, cardiovascular events (CVE) and all-cause mortality (ACM) of pat...
Autores principales: | Cunillera-Puértolas, Oriol, Vizcaya, David, Cerain-Herrero, M. Jesús, Gil-Terrón, Neus, Cobo-Guerrero, Silvia, Salvador-González, Betlem |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805248/ https://www.ncbi.nlm.nih.gov/pubmed/36585634 http://dx.doi.org/10.1186/s12882-022-02966-6 |
Ejemplares similares
-
Final Stage of Chronic Kidney Disease with Conservative Kidney Management or Renal Replacement Therapy: A Primary-Care Population Study
por: Bundó, Daniel, et al.
Publicado: (2023) -
Enfermedad renal crónica en Atención Primaria: prevalencia y factores de riesgo asociados
por: Salvador González, Betlem, et al.
Publicado: (2015) -
Evaluating the controlled reopening of nightlife during the COVID-19 pandemic: a matched cohort study in Sitges, Spain, in May 2021 (Reobrim Sitges)
por: Cunillera Puértolas, Oriol, et al.
Publicado: (2022) -
Correction to: Double-blind placebo-controlled randomized clinical trial to assess the efficacy of montelukast in mild to moderate respiratory symptoms of patients with long COVID: E-SPERANZA COVID Project study protocol
por: Mera-Cordero, Francisco, et al.
Publicado: (2022) -
Double-blind placebo-controlled randomized clinical trial to assess the efficacy of montelukast in mild to moderate respiratory symptoms of patients with long COVID: E-SPERANZA COVID Project study protocol
por: Mera-Cordero, Francisco, et al.
Publicado: (2022)